A Multicenter, Randomized, Double-blinded, Placebo-Controlled Phase III Trial to Evaluate Efficacy and Safety of Picankibart in Moderate-to-Severe Plaque Psoriasis

Name: A Multicenter, Randomized, Double-blinded, Placebo-Controlled Phase III Trial to Evaluate Efficacy and Safety of Picankibart in Moderate-to-Severe Plaque Psoriasis
Creator: Yunlu Gao
Published: 2026-03-30T15:32:14.360Z
Keywords: Dermatology, Clinical Trial

Gao, Yunlu; Qin, Lanying; Li, Yumei; Cui, Yong; Zhang, Shifa; Liu, Lunfei; Wang, Lihua; Ci, Chao; Lu, Jianyun; Chen, Rixin; Feng, Yanyan; Li, Shanshan; Cai, Chenghang; Chen, Mingxia; Han-Zhang, Han; Li, Yue; Qian, Lei; Shi, Yuling

doi:10.17632/24z74gd9tz.1

A Multicenter, Randomized, Double-blinded, Placebo-Controlled Phase III Trial to Evaluate Efficacy and Safety of Picankibart in Moderate-to-Severe Plaque Psoriasis

Published: 30 March 2026| Version 1 | DOI: 10.17632/24z74gd9tz.1

Contributors:

Yunlu Gao, Lanying Qin, Yumei Li, Yong Cui, Shifa Zhang, Lunfei Liu, Lihua Wang, Chao Ci, Jianyun Lu, Rixin Chen, Yanyan Feng, Shanshan Li, Chenghang Cai, Mingxia Chen, Han Han-Zhang, Yue Li, Lei Qian, Yuling Shi

Description

Supplementary file to: A Multicenter, Randomized, Double-blinded, Placebo-Controlled Phase III Trial to Evaluate Efficacy and Safety of Picankibart in Moderate-to-Severe Plaque Psoriasis

Files

Funders

Innovent Biologics Co. Ltd., Suzhou, China

A Multicenter, Randomized, Double-blinded, Placebo-Controlled Phase III Trial to Evaluate Efficacy and Safety of Picankibart in Moderate-to-Severe Plaque Psoriasis

Description

Files

Categories

Funders

Licence